Characterizing SARS-CoV-2-specific immunity in convalescent individuals: HVTN 405/HPTN 1901
A study to describe immune responses in study participants with a history of infection with SARS-CoV-2, the virus that causes COVID-19
Sponsor: NIH
Enrolling: Male and Female Patients
Study Length: 15 Months
Clinic Visits: 4
IRB Number: AAAT0172
Contact: Brett Gray, ANP, MPH: 201-528-3504 /
Additional Study Information: The HIV Vaccine Trials Network (HVTN) and Columbia University Irving Medical Center are doing a study to learn more about SARS-CoV-2 infection and the COVID-19 disease that it can cause. The purpose of this study is to learn more about infection with and recovery from the virus called SARS-CoV-2. Some people know this virus by the name coronavirus. It can cause the disease called COVID-19. You are being asked to take part in this study because you are age 18 or older and have recovered from COVID-19. Your participation in this study will last for at least 1 visit and may last up to about 1 year. These visits could last from an hour to 2 hours. Procedures will include blood draws and optional nasal sample collections at one required visit and 3 optional visits. About 400 people will take part in this study at multiple sites across the United States and South America. The information gained from this study will help us prepare for COVID-19 vaccine studies. You will receive compensation through a reloadable debit card, which will be provided to you.
This study is closed
Magdalena Sobieszczyk, MD
Do You Qualify?
Have you had a positive test for COVID_19 Yes No
Have you recovered from COIVID-19? Yes No
Are you above the age of 18? Yes No
Are you willing to come to the clinic for up to 4 visits? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Brett Gray, ANP, MPH